Corixa Corporation is a product development company engaged in developing immunology-based products that regulate innate immune responses. The Company's products include vaccine adjuvants, and toll-like receptor 4 agonists and antagonists. Vaccine adjuvants are compounds or additives that, when combined with a vaccine, boost the body's immune response to antigens contained in the vaccine. TLR4 agonists and antagonists are compounds that interact with a type of cell surface receptor that recognizes distinct molecular signatures presented by invading pathogens and generates an immune... response. These multiple product candidates are in late-stage human clinical trials. Corixa sells products to and records collaborative revenue from a limited number of pharmaceutical and biotechnology companies. Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operates a laboratory and production facility in Hamilton, Montana.
more